Pfizer Inc.
(PFE)
Add Watchlist
28.64 USD -0.03
Closed: 17 May, 3:55 pm
Symbol PFE
Market Cap 162.2B
Price 28.64
Open 28.90
52-wk High 40.37
50 Day Avg 27.16
Earnings Announcement 2024-07-30
Website https://www.pfizer.com
Name Pfizer Inc.
Shares Outstanding 5,666,590,000
Change % -0.9682%
Low 28.51
52-wk Low 25.20
200 Day Avg 29.88
Last Dividend 1.68
Exchange NYSE
Volume 25,657,819
Previous Close 28.92
High 28.91
EPS -0.05
PE -572.80
Avg Volume 42,738,561
CUSIP 717081103
Pfizer Inc. Outlook
Description Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Currency USD
ISIN US7170811035
Industry Drug Manufacturers - General
Changes -0.28
CUSIP 717081103
Range 25.20 - 40.37
Beta 0.59
CIK 0000078003

Pfizer Inc. News

17-May-2024 5:41 PM

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

17-May-2024 12:00 PM

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports

Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the Financial Times reported on Friday.

17-May-2024 10:06 AM

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

17-May-2024 7:11 AM

7 Value Stocks to Buy and Hold for a Decade of Dominance

Finding equities with the potential for steady, long-term development is crucial. These seven prospects span a variety of industries and offer solid arguments for long-term investment.

16-May-2024 11:00 PM

Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield

Pfizer's stock has struggled to recover since the pandemic, but its high dividend yield of 5.9% makes it an attractive option for income investors. The company faces risks from upcoming patent expiries and the impact of rising interest rates on its debt and ability to invest in research and development. Despite these challenges, Pfizer's valuation metrics suggest it is attractively priced, and a dividend discount model estimates a potential upside of over 30% from the current price level.

16-May-2024 9:45 AM

2 Top Growth Stocks Down 24% and 50% to Buy With $100

While healthcare is broadly resilient in times of economic stress, each company needs its own evaluation. Pfizer is dealing with a period of transition, but its business has only been bolstered by pandemic successes.

16-May-2024 9:00 AM

Dividend Harvesting Portfolio Week 167: $16,700 Allocated, $1,495.50 In Projected Dividends

The combination of earnings season and a dovish Fed are pushing the markets closer to all-time highs. The Dividend Harvesting Portfolio has reached an all-time high in profitability and account value, with a 13.14% return on invested capital. The portfolio is generating $1,495.50 in forward dividend income, with equities, ETFs, REITs, CEFs, and BDCs contributing to the dividend income.

16-May-2024 7:15 AM

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

It's no secret that artificial intelligence ( AI ) promises to transform every industry and sector, pharma included. But how do those companies plan to leverage AI, and what will it do for their stocks?

16-May-2024 12:12 AM

Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports

Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financial Times reported on Thursday.

15-May-2024 8:45 AM

Pfizer: Best Trading Momentum Since 2021 And 6% Yield

Pfizer: Best Trading Momentum Since 2021 And 6% Yield

15-May-2024 5:21 AM

3 No-Brainer Stocks to Buy With $500 Right Now

Stocks have handily outperformed all other asset classes in annualized returns over the last century. Most online brokers have made it easier than ever for retail investors to put their money to work on Wall Street.